Research Article
GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity
Table 4
Relationship between the expression of GPM6B in prostate cancer and clinicopathological parameters.
| Characteristics | | GPM6B | GPM6B | | value |
| Age | | | | | | ≥70 | 48 | 25 | 21 | 1.514 | 0.219 | <70 | 46 | 20 | 28 | | | Clinical stage | | | | | | III, IV | 63 | 24 | 39 | 7.318 | 0.007 | I, II | 31 | 21 | 10 | | | Gleason score | | | | | | ≥7 | 58 | 24 | 34 | 2.559 | 0.110 | <7 | 36 | 21 | 15 | | | T classification | | | | | | T3, T4 | 32 | 10 | 22 | 5.372 | 0.020 | T1, T2 | 62 | 35 | 27 | | | Lymph node metastasis | | | | | | Present | 15 | 3 | 12 | 5.556 | 0.018 | Absent | 79 | 42 | 37 | | | Distant metastasis | | | | | | Present | 29 | 9 | 20 | 4.765 | 0.029 | Absent | 65 | 36 | 29 | | |
|
|